More about
Persistent Atopic Dermatitis
CME
Video
Moderate-to-Severe Atopic Dermatitis: Optimizing Care Across Specialties
This activity is supported by an educational grant from Sanofi and Regeneron Pharmaceuticals.
CME
Video
Mastering Hand and Foot Atopic Dermatitis: From Immunology to Innovative Treatments
This activity is supported by an educational grant from Sanofi and Regeneron Pharmaceuticals.
CME
Monograph
Moderate-to-Severe Atopic Dermatitis: Separating Fact From Myth in Primary Care
This activity is supported by an educational grant from Sanofi and Regeneron Pharmaceuticals.
CME
Video
Getting Under the Skin: Updates in the Treatment of Pediatric Atopic Dermatitis
This activity is supported by an educational grant from Sanofi and Regeneron Pharmaceuticals.
News
February 11, 2023
1 min read
Save
Dupixent shows consistent, long-term efficacy in real-world studies
MIAMI BEACH, Florida — In two-real world studies, Dupixent treatment led to similar rapid and sustained improvements in patients with atopic dermatitis, according to a poster presentation at South Beach Symposium.